[Expectation for new-generation drug eluting stents].
Drug eluting stent (DES) dramatically reduced the instent restenosis(ISR). However, very late stent thrombosis appeared as another significant problem especially after the termination of dual antiplatelet therapy. The next-generation DESs are characterized by either biodegradable polymer, controlled drug delivery or biodegradable stent. By the introduction of these DESs, it is expected to reduce any long-term sequels while ensuring the reduction of ISR.